These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22994584)

  • 1. Probable levetiracetam-related serum alkaline phosphatase elevation.
    Xiong N; Hou L; Lu N; Mohamed AA; Wang T; Huang Y
    BMC Neurol; 2012 Sep; 12():97. PubMed ID: 22994584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures.
    Kumar N; Swaroop HS; Chakraborty A; Chandran S
    Indian J Pharmacol; 2014; 46(5):560-1. PubMed ID: 25298593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
    Serin HM; Koç ZP; Temelli B; Esen İ
    Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective analysis of the outcome of levetiracetam in clinical practice.
    Nicolson A; Lewis SA; Smith DF
    Neurology; 2004 Aug; 63(3):568-70. PubMed ID: 15304598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
    Shukla G; Gupta A; Agarwal P; Poornima S
    Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy.
    Hu FY; Wang W; Ren JC; An DM; Chen JN; Zhou D
    Epilepsy Res; 2016 Aug; 124():12-5. PubMed ID: 27162008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases.
    Dinkelacker V; Dietl T; Widman G; Lengler U; Elger CE
    Epilepsy Behav; 2003 Oct; 4(5):537-47. PubMed ID: 14527496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous levetiracetam as treatment for status epilepticus.
    Berning S; Boesebeck F; van Baalen A; Kellinghaus C
    J Neurol; 2009 Oct; 256(10):1634-42. PubMed ID: 19458986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of levetiracetam because of behavioral side effects: a case-control study.
    White JR; Walczak TS; Leppik IE; Rarick J; Tran T; Beniak TE; Matchinsky DJ; Gumnit RJ
    Neurology; 2003 Nov; 61(9):1218-21. PubMed ID: 14610123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute liver injury induced by levetiracetam and temozolomide co-treatment.
    Khoury T; Chen S; Abu Rmeileh A; Daher S; Yaari S; Benson AA; Cohen J; Mizrahi M
    Dig Liver Dis; 2017 Mar; 49(3):297-300. PubMed ID: 28034663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
    Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
    Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
    Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
    Ben-Menachem E; Gilland E
    Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up study on levetiracetam monotherapy in children with epilepsy].
    Gao ZJ; Jiang YW
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):711-4. PubMed ID: 19102836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam monotherapy in juvenile myoclonic epilepsy.
    Sharpe DV; Patel AD; Abou-Khalil B; Fenichel GM
    Seizure; 2008 Jan; 17(1):64-8. PubMed ID: 17692537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria.
    Dericioglu N; Saygi S
    Metab Brain Dis; 2010 Jun; 25(2):207-9. PubMed ID: 20424903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable levetiracetam-associated depression in the elderly: two case reports.
    Vande Griend JP; Linnebur SA; Bainbridge JL
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):281-4. PubMed ID: 19948304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell aplasia and hypogammaglobulinemia associated with levetiracetam.
    Ozdemir H; Sumer S; Karabagli H; Akdemir G; Caliskaner AZ; Artac H
    Ann Saudi Med; 2018; 38(1):65-68. PubMed ID: 29313528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.